Understanding how tRNA affects protein synthesis and cell health
tRNA in codon usage
This study looks at how tiny molecules called transfer RNA (tRNA) help make proteins in our cells and how certain changes to them can affect cell health and growth, especially focusing on a specific change that helps keep everything running smoothly during this process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10791832 on NIH RePORTER |
What this research studies
This research investigates the role of transfer RNA (tRNA) in the process of protein synthesis, focusing on how different codon usages can impact cell fitness and health. It examines the importance of post-transcriptional modifications, particularly the N1-methylation of guanine in tRNA, which is crucial for maintaining the correct reading frame during protein synthesis. By studying how these modifications influence the translation of specific amino acids, particularly proline, the research aims to uncover new biological mechanisms that could affect cell growth and survival.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with genetic disorders or diseases that affect protein synthesis and cell growth.
Not a fit: Patients with conditions unrelated to protein synthesis or those not experiencing issues with cell growth may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into cellular health and mechanisms that prevent cell death, potentially informing treatments for various diseases.
How similar studies have performed: While the specific focus on post-transcriptional modifications in tRNA is relatively novel, previous studies have shown success in understanding the role of tRNA in protein synthesis.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Hou, Ya-Ming — Thomas Jefferson University
- Study coordinator: Hou, Ya-Ming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.